Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Consolidated Net Income: 2013-2018

Historic Consolidated Net Income for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to -$1.1 million.

  • Armata Pharmaceuticals' Consolidated Net Income rose 53.19% to -$1.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$15.9 million, marking a year-over-year decrease of 63.16%. This contributed to the annual value of -$53.2 million for FY2024, which is 22.71% down from last year.
  • Latest data reveals that Armata Pharmaceuticals reported Consolidated Net Income of -$1.1 million as of Q4 2018, which was up 60.27% from -$2.8 million recorded in Q3 2018.
  • Armata Pharmaceuticals' 5-year Consolidated Net Income high stood at -$779,000 for Q3 2017, and its period low was -$11.3 million during Q1 2014.
  • Its 3-year average for Consolidated Net Income is -$3.9 million, with a median of -$3.1 million in 2016.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first plummeted by 691.25% in 2014, then skyrocketed by 76.61% in 2017.
  • Armata Pharmaceuticals' Consolidated Net Income (Quarterly) stood at -$2.6 million in 2014, then decreased by 10.40% to -$2.9 million in 2015, then crashed by 250.75% to -$10.1 million in 2016, then soared by 76.61% to -$2.4 million in 2017, then soared by 53.19% to -$1.1 million in 2018.
  • Its last three reported values are -$1.1 million in Q4 2018, -$2.8 million for Q3 2018, and -$9.7 million during Q2 2018.